SCHEMBL5815424

SCHEMBL5815424

Fc1ccccc1-c1nc(N2CCCCC2)sc1-c1ccnc(NC2CCCC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.45
CDK4 P11802 7/20 0.43
CCND1 P24385 5/20 0.43
CCND3 P30281 2/20 0.43
CDK6 Q00534 2/20 0.43
MAPK10 P53779 1/20 0.43
CDK1 P06493 7/20 0.43
CCNB1 P14635 7/20 0.43
CCNB2 O95067 4/20 0.43
CCNB3 Q8WWL7 4/20 0.43
GSK3B P49841 3/20 0.42
CDC7 O00311 1/20 0.42
PLK4 O00444 1/20 0.42
JAK2 O60674 1/20 0.42
MAP4K4 O95819 1/20 0.42
INSR P06213 1/20 0.42
CSF1R P07333 1/20 0.42
PIM1 P11309 1/20 0.42
PRKACA P17612 1/20 0.42
FLT1 P17948 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812777 1.00 KCNH2 (0.45) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5813694 0.97 KCNH2 (0.45) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5818778 0.93 HRH4 (0.50) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5814648 0.93 KCNH2 (0.50) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5818639 0.93 CDK1 (0.42) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5817256 0.92 HRH4 (0.51) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5813653 0.92 KCNH2 (0.51) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5813579 0.92 HRH4 (0.42) KCNH2CDK4CCND1CCND3CDK6
SCHEMBL5812995 0.88 KCNH2 (0.39) KCNH2CDK4MAPK10CDK1CCNB1
SCHEMBL5818808 0.88 KCNH2 (0.50) KCNH2CDK4CCND1CCND3CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed